The international independent ranking organisation AD Scientific Index is more than an ordinary "Ranking". The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings, University Subject Rankings and Universities Rankings 2024 (Sort by: Last 6 years H Index). Click here for individual or institutional registration.
![Rod Hicks](/pictures/8c/4374992.jpg)
![Joseph A Trapani](/images/no-picture.png)
![Steven A. Stacker](/pictures/6a/4374995.jpg)
![Monica Slavin](/pictures/a7/4387930.jpg)
![Declan G Murphy](/pictures/5e/4389478.jpg)
![Riccardo Dolcetti](/pictures/21/4389976.jpg)
![Jayesh Desai](/images/no-picture.png)
![Prudence A. Francis](/pictures/d5/4389483.jpg)
![Michael Jefford](/pictures/0a/4387534.jpg)
![Prue Cormie](/pictures/79/4389484.jpg)
![Leon Worth](/pictures/6c/4385816.jpg)
![Paul Beavis](/pictures/a9/4388884.jpg)
AD Scientific Index - World Scientists Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
3 | 210 | 219 | 5,711 |
|
![]() |
![]() |
Others
|
111 | 69 | 0.622 | 243 | 195 | 0.802 | 55,343 | 24,494 | 0.443 |
4 | 243 | 256 | 6,524 |
|
![]() |
![]() |
Others
Cancer | |
107 | 74 | 0.692 | 349 | 255 | 0.731 | 85,676 | 40,685 | 0.475 |
5 | 286 | 300 | 7,609 |
|
![]() |
![]() |
Others
Molecular Imaging | Positron emission tomography | Oncology | |
103 | 64 | 0.621 | 474 | 324 | 0.684 | 41,222 | 20,041 | 0.486 |
6 | 335 | 351 | 8,630 |
|
![]() |
![]() |
Others
Cancer Immunology | immune killer cells | perforin | granzymes | CAR T cells | |
100 | 53 | 0.530 | 290 | 195 | 0.672 | 37,393 | 11,730 | 0.314 |
7 | 367 | 383 | 9,228 |
|
![]() |
![]() |
Others
Cancer | |
98 | 61 | 0.622 | 239 | 175 | 0.732 | 41,723 | 14,201 | 0.340 |
10 | 759 | 802 | 16,893 |
|
![]() |
![]() |
Others
|
83 | 51 | 0.614 | 340 | 185 | 0.544 | 29,739 | 12,258 | 0.412 |
11 | 854 | 904 | 18,626 |
|
![]() |
![]() |
Others
Angiogenesis | lymphangiogenesis | growth factors | receptors | |
81 | 40 | 0.494 | 166 | 92 | 0.554 | 30,063 | 5,978 | 0.199 |
12 | 1,084 | 1,151 | 22,832 |
|
![]() |
![]() |
Others
|
76 | 45 | 0.592 | 258 | 158 | 0.612 | 30,446 | 12,222 | 0.401 |
15 | 1,279 | 1,364 | 26,773 |
|
![]() |
![]() |
Others
Infections in Immunocompromised hosts | |
72 | 54 | 0.750 | 286 | 219 | 0.766 | 22,511 | 13,706 | 0.609 |
17 | 1,560 | 1,666 | 32,021 |
|
![]() |
![]() |
Others
prostate cancer genitourinary oncology robotic surgery social media cancer imaging | |
68 | 51 | 0.750 | 256 | 199 | 0.777 | 20,166 | 14,486 | 0.718 |
![]() |
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
![]() |
||||||||||||||
20 | 1,845 | 1,980 | 37,726 |
|
![]() |
![]() |
Others
Cancer | immunotherapy | infection-associated tumors | |
65 | 34 | 0.523 | 210 | 105 | 0.500 | 16,757 | 5,394 | 0.322 |
22 | 1,951 | 2,098 | 39,701 |
|
![]() |
![]() |
Others
|
64 | 32 | 0.500 | 124 | 85 | 0.685 | 16,437 | 5,193 | 0.316 |
23 | 2,079 | 2,239 | 42,323 |
|
![]() |
![]() |
Others
Drug Development | Phase I Trials | Sarcoma | Colorectal Cancer | |
62 | 49 | 0.790 | 189 | 146 | 0.772 | 27,831 | 17,140 | 0.616 |
24 | 2,215 | 2,389 | 44,882 |
|
![]() |
![]() |
Others
Breast | |
61 | 42 | 0.689 | 152 | 110 | 0.724 | 17,878 | 10,414 | 0.583 |
28 | 2,423 | 2,615 | 49,098 |
|
![]() |
![]() |
Others
|
59 | 45 | 0.763 | 166 | 133 | 0.801 | 18,652 | 12,659 | 0.679 |
30 | 2,546 | 2,753 | 51,514 |
|
![]() |
![]() |
Others
Breast Cancer | Clinical Trials | |
58 | 44 | 0.759 | 113 | 80 | 0.708 | 20,455 | 12,689 | 0.620 |
32 | 2,854 | 3,092 | 57,078 |
|
![]() |
![]() |
Others
GI oncology / survivorship / supportive care | |
56 | 40 | 0.714 | 153 | 106 | 0.693 | 10,364 | 4,923 | 0.475 |
35 | 3,813 | 4,173 | 76,626 |
|
![]() |
![]() |
Others
Exercise Oncology | |
50 | 42 | 0.840 | 84 | 79 | 0.940 | 13,271 | 6,906 | 0.520 |
36 | 3,816 | 4,177 | 76,698 |
|
![]() |
![]() |
Others
|
50 | 41 | 0.820 | 124 | 101 | 0.815 | 13,165 | 10,387 | 0.789 |
37 | 4,352 | 4,776 | 87,816 |
|
![]() |
![]() |
Others
lymphoma | |
48 | 27 | 0.563 | 109 | 58 | 0.532 | 9,412 | 3,397 | 0.361 |
38 | 4,529 | 4,988 | 91,629 |
|
![]() |
![]() |
Others
|
47 | 31 | 0.660 | 74 | 58 | 0.784 | 9,788 | 4,742 | 0.484 |
39 | 4,953 | 5,462 | 100,658 |
|
![]() |
![]() |
Others
Infections in the immunocompromised host | Healthcare-associated infections | |
45 | 33 | 0.733 | 124 | 100 | 0.806 | 6,057 | 3,499 | 0.578 |
43 | 5,695 | 6,292 | 116,257 |
|
![]() |
![]() |
Others
Cancer Immunotherapy | CAR T cells | adenosine | |
42 | 39 | 0.929 | 53 | 51 | 0.962 | 10,493 | 8,634 | 0.823 |
45 | 6,313 | 6,992 | 129,014 |
|
![]() |
![]() |
Others
|
41 | 15 | 0.366 | 97 | 28 | 0.289 | 6,933 | 923 | 0.133 |
47 | 6,425 | 7,109 | 131,079 |
|
![]() |
![]() |
Others
|
40 | 32 | 0.800 | 81 | 72 | 0.889 | 6,451 | 3,148 | 0.488 |